BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34010407)

  • 1. Toward prevention of childhood ALL by early-life immune training.
    Hauer J; Fischer U; Borkhardt A
    Blood; 2021 Oct; 138(16):1412-1428. PubMed ID: 34010407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Utero Development and Immunosurveillance of B Cell Acute Lymphoblastic Leukemia.
    Rüchel N; Jepsen VH; Hein D; Fischer U; Borkhardt A; Gössling KL
    Curr Treat Options Oncol; 2022 Apr; 23(4):543-561. PubMed ID: 35294722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection Exposure Promotes
    Rodríguez-Hernández G; Hauer J; Martín-Lorenzo A; Schäfer D; Bartenhagen C; García-Ramírez I; Auer F; González-Herrero I; Ruiz-Roca L; Gombert M; Okpanyi V; Fischer U; Chen C; Dugas M; Bhatia S; Linka RM; Garcia-Suquia M; Rascón-Trincado MV; Garcia-Sanchez A; Blanco O; García-Cenador MB; García-Criado FJ; Cobaleda C; Alonso-López D; De Las Rivas J; Müschen M; Vicente-Dueñas C; Sánchez-García I; Borkhardt A
    Cancer Res; 2017 Aug; 77(16):4365-4377. PubMed ID: 28630052
    [No Abstract]   [Full Text] [Related]  

  • 4. Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia.
    Vijayakrishnan J; Studd J; Broderick P; Kinnersley B; Holroyd A; Law PJ; Kumar R; Allan JM; Harrison CJ; Moorman AV; Vora A; Roman E; Rachakonda S; Kinsey SE; Sheridan E; Thompson PD; Irving JA; Koehler R; Hoffmann P; Nöthen MM; Heilmann-Heimbach S; Jöckel KH; Easton DF; Pharaoh PDP; Dunning AM; Peto J; Canzian F; Swerdlow A; Eeles RA; Kote-Jarai Z; Muir K; Pashayan N; ; Greaves M; Zimmerman M; Bartram CR; Schrappe M; Stanulla M; Hemminki K; Houlston RS
    Nat Commun; 2018 Apr; 9(1):1340. PubMed ID: 29632299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of ETV6/RUNX1 and MLL aberrations in B-cell precursor acute lymphoblastic leukemia discloses a small subclass of BCP-ALL.
    Amare Kadam PS; Raje GC; Pais AP; Banavali S
    Cancer Genet Cytogenet; 2008 Apr; 182(1):27-32. PubMed ID: 18328947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
    Ghazavi F; De Moerloose B; Van Loocke W; Wallaert A; Helsmoortel HH; Ferster A; Bakkus M; Plat G; Delabesse E; Uyttebroeck A; Van Nieuwerburgh F; Deforce D; Van Roy N; Speleman F; Benoit Y; Lammens T; Van Vlierberghe P
    Oncotarget; 2016 Nov; 7(45):73769-73780. PubMed ID: 27650541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordant B-cell precursor acute lymphoblastic leukemia in non-twinned siblings.
    Pombo-de-Oliveira MS; Emerenciano M; Winn AP; Costa I; Mansur MB; Ford AM
    Blood Cells Mol Dis; 2015 Jan; 54(1):110-5. PubMed ID: 25150625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.
    Zaliova M; Kotrova M; Bresolin S; Stuchly J; Stary J; Hrusak O; Te Kronnie G; Trka J; Zuna J; Vaskova M
    Genes Chromosomes Cancer; 2017 Aug; 56(8):608-616. PubMed ID: 28395118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
    Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M
    Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells.
    Ford AM; Palmi C; Bueno C; Hong D; Cardus P; Knight D; Cazzaniga G; Enver T; Greaves M
    J Clin Invest; 2009 Apr; 119(4):826-36. PubMed ID: 19287094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.
    Hong D; Gupta R; Ancliff P; Atzberger A; Brown J; Soneji S; Green J; Colman S; Piacibello W; Buckle V; Tsuzuki S; Greaves M; Enver T
    Science; 2008 Jan; 319(5861):336-9. PubMed ID: 18202291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
    Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
    Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious triggers and novel therapeutic opportunities in childhood B cell leukaemia.
    Cobaleda C; Vicente-Dueñas C; Sanchez-Garcia I
    Nat Rev Immunol; 2021 Sep; 21(9):570-581. PubMed ID: 33558682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse.
    Sun C; Chang L; Zhu X
    Oncotarget; 2017 May; 8(21):35445-35459. PubMed ID: 28418909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
    Jakobczyk H; Debaize L; Soubise B; Avner S; Rouger-Gaudichon J; Commet S; Jiang Y; Sérandour AA; Rio AG; Carroll JS; Wichmann C; Lie-A-Ling M; Lacaud G; Corcos L; Salbert G; Galibert MD; Gandemer V; Troadec MB
    J Hematol Oncol; 2021 Mar; 14(1):47. PubMed ID: 33743795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Tel-Aml1 transcript variants in pediatric acute lymphoblastic leukemia.
    Kustanovich AM; Belevtsev MV; Stasevich IV; Savitskaya TV; Jutzkevich RI; Savva NN; Aleinikova OV
    Leukemia; 2006 Jan; 20(1):165-7. PubMed ID: 16307024
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel ETV6-RUNX1 Mouse Model to Study the Role of ELF-MF in Childhood B-Acute Lymphoblastic Leukemia: a Pilot Study.
    Campos-Sanchez E; Vicente-Dueñas C; Rodríguez-Hernández G; Capstick M; Kuster N; Dasenbrock C; Sánchez-García I; Cobaleda C
    Bioelectromagnetics; 2019 Jul; 40(5):343-353. PubMed ID: 31157932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL.
    Pais AP; Amare Kadam PS; Raje GC; Banavali S; Parikh P; Kurkure P; Arora B; Gujral S; Kumar SA; Badrinath Y
    Pediatr Hematol Oncol; 2008 Sep; 25(6):582-97. PubMed ID: 18728978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.
    Alm SJ; Engvall C; Asp J; Palmqvist L; Abrahamsson J; Fogelstrand L
    Int J Lab Hematol; 2017 Apr; 39(2):121-128. PubMed ID: 28004528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significantly increased CD70 up regulation on TEL-AML positive B cell precursor acute lymphoblastic leukemia cells following CD40 stimulation.
    Troeger A; Glouchkova L; Ackermann B; Escherich G; Hanenberg H; Janka G; Roettgers S; Göbel U; Dilloo D
    Klin Padiatr; 2014 Nov; 226(6-7):332-7. PubMed ID: 25062112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.